Caliper Aims to Become Microfluidics Mega-Manufacturer | GenomeWeb

NEW YORK, March 22 - Caliper Technologies wants to sell microfluidics chips the way Gillette sells razor blades -- and there is growing evidence that they are succeeding.

”The power in our technology is in the chip, not in the instrument that reads it,” Jim Knighton, Caliper's chief financial officer, recently told GenomeWeb. “This will distinguish us from a lot of current instrument manufacturers we will be competing with.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.